Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Dave Gore who wrote (14797)	5/5/1998 6:54:00 PM
From: KonKilo	Respond to of 34592

Down my way, the '60's didn't end until around '73...

To: Dave Gore who wrote (14797)	5/5/1998 6:55:00 PM
From: Due Diligence	Respond to of 34592

When from Preppie to Hippie back to Preppie again Hippie, then work. Now, just a dirty Ole Man.Har. Jimbo

To: Dave Gore who wrote (14797)	5/5/1998 6:57:00 PM
From: Instock	Read Replies (1) \| Respond to of 34592

TCLN Cancer news! Largest volume and price leader today. Will get MUCH evening Media attention tonight and the coming days. IMO Money line and NBR should both have favoable mentions tonight about TCLN. Cancer News is always HOT news! Techniclone cites cancer technology TUSTIN, Calif., May 5 (Reuters) - Techniclone Corp said Tuesday its vascular targeting agent technology has the potential to kill cancerous tumors by targeting and killing tumor blood vessels. Techniclone's stock rose 28/32 to 1-23/32. It said its research has yielded several candidates shown to eliminate large tumors in preclinical studies in animals. The biotechnology company said it is committed to preparing compounds for preclinical and clinical development in the vascular targeting field. It expects clinical plans to first focus on treatment of established primary tumors rather than inhibiting growth of recurrent or secondary tumors.